Log In
BCIQ
Print this Print this
 

CF-402

  Manage Alerts
Collapse Summary General Information
Company ContraFect Corp.
DescriptionNot disclosed
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentDiscovery
Standard IndicationInfluenza virus
Indication DetailsTreat influenza type A
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today